Oxford Biomedica (LON:OXB) Hits New 52-Week High – Here’s Why

by · The Markets Daily

Oxford Biomedica plc (LON:OXB – Get Free Report)’s stock price reached a new 52-week high during mid-day trading on Friday . The stock traded as high as GBX 446.01 ($5.79) and last traded at GBX 445 ($5.78), with a volume of 210719 shares traded. The stock had previously closed at GBX 428.50 ($5.56).

Analysts Set New Price Targets

Separately, Deutsche Bank Aktiengesellschaft increased their price target on Oxford Biomedica from GBX 250 ($3.25) to GBX 380 ($4.93) and gave the stock a “hold” rating in a report on Tuesday, September 24th.

Check Out Our Latest Analysis on OXB

Oxford Biomedica Stock Performance

The company has a current ratio of 2.35, a quick ratio of 1.67 and a debt-to-equity ratio of 154.88. The stock has a market capitalization of £468.85 million, a price-to-earnings ratio of -292.36 and a beta of 1.09. The firm’s fifty day moving average price is GBX 363.14 and its 200 day moving average price is GBX 328.14.

Oxford Biomedica Company Profile

(Get Free Report)

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.

Featured Stories